Kerala Ayurveda Ltd
Kerala Ayurveda's capital structure is highly leveraged, with a debt-to-equity ratio of 7.44, indicating significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.46, and it holds only INR 33.89 million in cash and equivalents, which is insufficient to cover its INR 1.19 billion in liabilities. The negative net cash position after subtracting total debt further exacerbates liquidity concerns. Profitability metrics are deeply negative, with a return on equity of -1.47 and a return on assets of -0.11, both well below industry medians for pharmaceutical and healthcare services firms. Operating income is negative at INR 99.66 million, and net income is also negative at INR 139.59 million, indicating a failure to generate sustainable earnings. The company's revenue is concentrated in its domestic operations in India, with no disclosed international revenue segments. This geographic concentration increases exposure to local economic and regulatory risks, particularly in the healthcare and pharmaceutical sectors. Growth trajectory is negative, with no disclosed revenue growth in recent periods. The company reported INR 1.2 billion in revenue, but this is accompanied by a free cash flow deficit of INR 223.12 million and capital expenditures of INR 133.28 million, suggesting reinvestment is not generating positive returns. Risk factors include high leverage, negative operating and net income, and weak liquidity. The risk assessment flags a medium liquidity risk and low dilution risk, but the negative net cash position is a key flag. No dilution sources are disclosed in recent filings, and the company has not issued shares at-the-market or through shelf offerings. Recent events include no disclosed earnings calls or 10-K filings, but the company's financial snapshot indicates a deteriorating operating performance. The negative operating cash flow of INR 48.33 million and free cash flow deficit suggest operational inefficiencies and poor capital allocation.
Business. Kerala Ayurveda Limited is an India-based company that produces Ayurveda products and provides Ayurveda research, academies, clinics, hospitals, wellness resorts, and services, with a focus on herbal cultivation and herbarium maintenance.
Classification. Kerala Ayurveda is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector, with a confidence level of 0.92.
- Kerala Ayurveda is highly leveraged with a debt-to-equity ratio of 7.44, indicating significant financial risk.
- The company is unprofitable, with negative return on equity and return on assets.
- Liquidity is weak, with a current ratio of 0.46 and insufficient cash to cover liabilities.
- Revenue is concentrated in India, increasing exposure to local economic and regulatory risks.
- Growth is negative, with no disclosed revenue growth and a free cash flow deficit.
- No dilution sources are currently active, but the company's financial position remains precarious.
- --
- ## RATIONALES
- Net cash is negative after subtracting total debt.